Sino Biopharmaceuticals set foot in the mainland eye hospital business
-
Last Update: 2014-01-14
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
China biopharma announced today that it has entered into a share transfer agreement with Pacific Medical and excelsior healthcare Accordingly, Pacific Medical and excelsior healthcare have conditionally agreed to sell 55% of its stake in Hong Kong Pacific Caritas investment to the company for a total consideration of 82.5 million yuan Hong Kong Pacific Caritas investment mainly provides medical services through its brand in Beijing, Nanchang, Jiangxi, Linyi, Shandong, Zhengzhou, Henan and other cities At present, it operates 5 eye hospitals, 5 optometry centers and a low vision prevention and treatment center for teenagers The reason for the acquisition is that the group is mainly engaged in research, development, production and sales of a variety of modern Chinese medicine preparations and chemicals to promote human health It plans to continue to actively develop ophthalmic hospitals in all parts of China, and enhance the brand of fraternity in optometry and ophthalmology market by cooperating with shareholders, exploring strategic investment opportunities and acquiring appropriate targets.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
